Skip to content
StrideBio
The next evolution in gene therapy
About
Founders
Executive Team
Board of Directors
Capsid Platform
AAV Manufacturing
Therapeutics
Patients
Our Commitment
Contact
News
Press Releases
Media
Investors
Careers
Contact
On heels of license deal, StrideBio secures seed funding from Hatteras Venture Partners
June 1, 2017
Back to News
©2022
SITE CREDITS
